目次

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market by Geography
Executive Summary - Chart on Market Segmentation by Route of Administration
Executive Summary - Chart on Market Segmentation by Drug Class
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning

2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis

3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global Atopic Dermatitis Drugs Market 2018 - 2022
Historic Market Size - Data Table on Global Atopic Dermatitis Drugs Market 2018 - 2022 ($ million)
4.2 Route of Administration segment analysis 2018 - 2022
Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
4.3 Drug Class segment analysis 2018 - 2022
Historic Market Size - Drug Class Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Route of Administration
6.1 Market segments
Chart on Route of Administration - Market share 2023-2028 (%)
Data Table on Route of Administration - Market share 2023-2028 (%)
6.2 Comparison by Route of Administration
Chart on Comparison by Route of Administration
Data Table on Comparison by Route of Administration
6.3 Oral - Market size and forecast 2023-2028
Chart on Oral - Market size and forecast 2023-2028 ($ million)
Data Table on Oral - Market size and forecast 2023-2028 ($ million)
Chart on Oral - Year-over-year growth 2023-2028 (%)
Data Table on Oral - Year-over-year growth 2023-2028 (%)
6.4 Topical - Market size and forecast 2023-2028
Chart on Topical - Market size and forecast 2023-2028 ($ million)
Data Table on Topical - Market size and forecast 2023-2028 ($ million)
Chart on Topical - Year-over-year growth 2023-2028 (%)
Data Table on Topical - Year-over-year growth 2023-2028 (%)
6.5 Injectable - Market size and forecast 2023-2028
Chart on Injectable - Market size and forecast 2023-2028 ($ million)
Data Table on Injectable - Market size and forecast 2023-2028 ($ million)
Chart on Injectable - Year-over-year growth 2023-2028 (%)
Data Table on Injectable - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Route of Administration
Market opportunity by Route of Administration ($ million)
Data Table on Market opportunity by Route of Administration ($ million)

7 Market Segmentation by Drug Class
7.1 Market segments
Chart on Drug Class - Market share 2023-2028 (%)
Data Table on Drug Class - Market share 2023-2028 (%)
7.2 Comparison by Drug Class
Chart on Comparison by Drug Class
Data Table on Comparison by Drug Class
7.3 Biologics - Market size and forecast 2023-2028
Chart on Biologics - Market size and forecast 2023-2028 ($ million)
Data Table on Biologics - Market size and forecast 2023-2028 ($ million)
Chart on Biologics - Year-over-year growth 2023-2028 (%)
Data Table on Biologics - Year-over-year growth 2023-2028 (%)
7.4 PDE4 inhibitors - Market size and forecast 2023-2028
Chart on PDE4 inhibitors - Market size and forecast 2023-2028 ($ million)
Data Table on PDE4 inhibitors - Market size and forecast 2023-2028 ($ million)
Chart on PDE4 inhibitors - Year-over-year growth 2023-2028 (%)
Data Table on PDE4 inhibitors - Year-over-year growth 2023-2028 (%)
7.5 Corticosteroids - Market size and forecast 2023-2028
Chart on Corticosteroids - Market size and forecast 2023-2028 ($ million)
Data Table on Corticosteroids - Market size and forecast 2023-2028 ($ million)
Chart on Corticosteroids - Year-over-year growth 2023-2028 (%)
Data Table on Corticosteroids - Year-over-year growth 2023-2028 (%)
7.6 Calcineurin inhibitors - Market size and forecast 2023-2028
Chart on Calcineurin inhibitors - Market size and forecast 2023-2028 ($ million)
Data Table on Calcineurin inhibitors - Market size and forecast 2023-2028 ($ million)
Chart on Calcineurin inhibitors - Year-over-year growth 2023-2028 (%)
Data Table on Calcineurin inhibitors - Year-over-year growth 2023-2028 (%)
7.7 Market opportunity by Drug Class
Market opportunity by Drug Class ($ million)
Data Table on Market opportunity by Drug Class ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape2023-2028 (%)
Data Table on Market share By Geographical Landscape2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.11 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity by geography
Market opportunity By Geographical Landscape($ million)
Data Tables on Market opportunity By Geographical Landscape($ million)

10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints

11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business

12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 AbbVie Inc.
AbbVie Inc. - Overview
AbbVie Inc. - Product / Service
AbbVie Inc. - Key news
AbbVie Inc. - Key offerings
12.4 Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc. - Overview
Arcutis Biotherapeutics Inc. - Product / Service
Arcutis Biotherapeutics Inc. - Key news
Arcutis Biotherapeutics Inc. - Key offerings
12.5 Bausch Health Companies Inc.
Bausch Health Companies Inc. - Overview
Bausch Health Companies Inc. - Business segments
Bausch Health Companies Inc. - Key news
Bausch Health Companies Inc. - Key offerings
Bausch Health Companies Inc. - Segment focus
12.6 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product / Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
12.7 Eli Lilly and Co.
Eli Lilly and Co. - Overview
Eli Lilly and Co. - Product / Service
Eli Lilly and Co. - Key news
Eli Lilly and Co. - Key offerings
12.8 Evelo Biosciences Inc.
Evelo Biosciences Inc. - Overview
Evelo Biosciences Inc. - Product / Service
Evelo Biosciences Inc. - Key offerings
12.9 Galderma SA
Galderma SA - Overview
Galderma SA - Product / Service
Galderma SA - Key offerings
12.10 Incyte Corp.
Incyte Corp. - Overview
Incyte Corp. - Product / Service
Incyte Corp. - Key offerings
12.11 LEO Pharma AS
LEO Pharma AS - Overview
LEO Pharma AS - Business segments
LEO Pharma AS - Key offerings
LEO Pharma AS - Segment focus
12.12 Maruho Co. Ltd.
Maruho Co. Ltd. - Overview
Maruho Co. Ltd. - Product / Service
Maruho Co. Ltd. - Key news
Maruho Co. Ltd. - Key offerings
12.13 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
12.14 Otsuka Holdings Co. Ltd.
Otsuka Holdings Co. Ltd. - Overview
Otsuka Holdings Co. Ltd. - Business segments
Otsuka Holdings Co. Ltd. - Key offerings
Otsuka Holdings Co. Ltd. - Segment focus
12.15 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
12.16 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
12.17 Viatris Inc.
Viatris Inc. - Overview
Viatris Inc. - Business segments
Viatris Inc. - Key news
Viatris Inc. - Key offerings
Viatris Inc. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits6: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Parent Market
Exhibits11: Data Table on - Parent Market
Exhibits12: Market characteristics analysis
Exhibits13: Value Chain Analysis
Exhibits14: Offerings of companies included in the market definition
Exhibits15: Market segments
Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits20: Historic Market Size - Data Table on Global Atopic Dermatitis Drugs Market 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Drug Class Segment 2018 - 2022 ($ million)
Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits25: Five forces analysis - Comparison between 2023 and 2028
Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits31: Chart on Market condition - Five forces 2023 and 2028
Exhibits32: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibits33: Data Table on Route of Administration - Market share 2023-2028 (%)
Exhibits34: Chart on Comparison by Route of Administration
Exhibits35: Data Table on Comparison by Route of Administration
Exhibits36: Chart on Oral - Market size and forecast 2023-2028 ($ million)
Exhibits37: Data Table on Oral - Market size and forecast 2023-2028 ($ million)
Exhibits38: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibits39: Data Table on Oral - Year-over-year growth 2023-2028 (%)
Exhibits40: Chart on Topical - Market size and forecast 2023-2028 ($ million)
Exhibits41: Data Table on Topical - Market size and forecast 2023-2028 ($ million)
Exhibits42: Chart on Topical - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on Topical - Year-over-year growth 2023-2028 (%)
Exhibits44: Chart on Injectable - Market size and forecast 2023-2028 ($ million)
Exhibits45: Data Table on Injectable - Market size and forecast 2023-2028 ($ million)
Exhibits46: Chart on Injectable - Year-over-year growth 2023-2028 (%)
Exhibits47: Data Table on Injectable - Year-over-year growth 2023-2028 (%)
Exhibits48: Market opportunity by Route of Administration ($ million)
Exhibits49: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits50: Chart on Drug Class - Market share 2023-2028 (%)
Exhibits51: Data Table on Drug Class - Market share 2023-2028 (%)
Exhibits52: Chart on Comparison by Drug Class
Exhibits53: Data Table on Comparison by Drug Class
Exhibits54: Chart on Biologics - Market size and forecast 2023-2028 ($ million)
Exhibits55: Data Table on Biologics - Market size and forecast 2023-2028 ($ million)
Exhibits56: Chart on Biologics - Year-over-year growth 2023-2028 (%)
Exhibits57: Data Table on Biologics - Year-over-year growth 2023-2028 (%)
Exhibits58: Chart on PDE4 inhibitors - Market size and forecast 2023-2028 ($ million)
Exhibits59: Data Table on PDE4 inhibitors - Market size and forecast 2023-2028 ($ million)
Exhibits60: Chart on PDE4 inhibitors - Year-over-year growth 2023-2028 (%)
Exhibits61: Data Table on PDE4 inhibitors - Year-over-year growth 2023-2028 (%)
Exhibits62: Chart on Corticosteroids - Market size and forecast 2023-2028 ($ million)
Exhibits63: Data Table on Corticosteroids - Market size and forecast 2023-2028 ($ million)
Exhibits64: Chart on Corticosteroids - Year-over-year growth 2023-2028 (%)
Exhibits65: Data Table on Corticosteroids - Year-over-year growth 2023-2028 (%)
Exhibits66: Chart on Calcineurin inhibitors - Market size and forecast 2023-2028 ($ million)
Exhibits67: Data Table on Calcineurin inhibitors - Market size and forecast 2023-2028 ($ million)
Exhibits68: Chart on Calcineurin inhibitors - Year-over-year growth 2023-2028 (%)
Exhibits69: Data Table on Calcineurin inhibitors - Year-over-year growth 2023-2028 (%)
Exhibits70: Market opportunity by Drug Class ($ million)
Exhibits71: Data Table on Market opportunity by Drug Class ($ million)
Exhibits72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits73: Chart on Market share By Geographical Landscape2023-2028 (%)
Exhibits74: Data Table on Market share By Geographical Landscape2023-2028 (%)
Exhibits75: Chart on Geographic comparison
Exhibits76: Data Table on Geographic comparison
Exhibits77: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits86: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits87: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits90: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits91: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits94: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits95: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits98: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits99: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits101: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits102: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits103: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits104: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits105: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits106: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits107: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits108: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits109: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits110: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits111: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits112: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits113: Market opportunity By Geographical Landscape($ million)
Exhibits114: Data Tables on Market opportunity By Geographical Landscape($ million)
Exhibits115: Impact of drivers and challenges in 2023 and 2028
Exhibits116: Overview on criticality of inputs and factors of differentiation
Exhibits117: Overview on factors of disruption
Exhibits118: Impact of key risks on business
Exhibits119: Companies covered
Exhibits120: Matrix on companies position and classification
Exhibits121: AbbVie Inc. - Overview
Exhibits122: AbbVie Inc. - Product / Service
Exhibits123: AbbVie Inc. - Key news
Exhibits124: AbbVie Inc. - Key offerings
Exhibits125: Arcutis Biotherapeutics Inc. - Overview
Exhibits126: Arcutis Biotherapeutics Inc. - Product / Service
Exhibits127: Arcutis Biotherapeutics Inc. - Key news
Exhibits128: Arcutis Biotherapeutics Inc. - Key offerings
Exhibits129: Bausch Health Companies Inc. - Overview
Exhibits130: Bausch Health Companies Inc. - Business segments
Exhibits131: Bausch Health Companies Inc. - Key news
Exhibits132: Bausch Health Companies Inc. - Key offerings
Exhibits133: Bausch Health Companies Inc. - Segment focus
Exhibits134: Bristol Myers Squibb Co. - Overview
Exhibits135: Bristol Myers Squibb Co. - Product / Service
Exhibits136: Bristol Myers Squibb Co. - Key news
Exhibits137: Bristol Myers Squibb Co. - Key offerings
Exhibits138: Eli Lilly and Co. - Overview
Exhibits139: Eli Lilly and Co. - Product / Service
Exhibits140: Eli Lilly and Co. - Key news
Exhibits141: Eli Lilly and Co. - Key offerings
Exhibits142: Evelo Biosciences Inc. - Overview
Exhibits143: Evelo Biosciences Inc. - Product / Service
Exhibits144: Evelo Biosciences Inc. - Key offerings
Exhibits145: Galderma SA - Overview
Exhibits146: Galderma SA - Product / Service
Exhibits147: Galderma SA - Key offerings
Exhibits148: Incyte Corp. - Overview
Exhibits149: Incyte Corp. - Product / Service
Exhibits150: Incyte Corp. - Key offerings
Exhibits151: LEO Pharma AS - Overview
Exhibits152: LEO Pharma AS - Business segments
Exhibits153: LEO Pharma AS - Key offerings
Exhibits154: LEO Pharma AS - Segment focus
Exhibits155: Maruho Co. Ltd. - Overview
Exhibits156: Maruho Co. Ltd. - Product / Service
Exhibits157: Maruho Co. Ltd. - Key news
Exhibits158: Maruho Co. Ltd. - Key offerings
Exhibits159: Novartis AG - Overview
Exhibits160: Novartis AG - Business segments
Exhibits161: Novartis AG - Key news
Exhibits162: Novartis AG - Key offerings
Exhibits163: Novartis AG - Segment focus
Exhibits164: Otsuka Holdings Co. Ltd. - Overview
Exhibits165: Otsuka Holdings Co. Ltd. - Business segments
Exhibits166: Otsuka Holdings Co. Ltd. - Key offerings
Exhibits167: Otsuka Holdings Co. Ltd. - Segment focus
Exhibits168: Pfizer Inc. - Overview
Exhibits169: Pfizer Inc. - Product / Service
Exhibits170: Pfizer Inc. - Key news
Exhibits171: Pfizer Inc. - Key offerings
Exhibits172: Sanofi SA - Overview
Exhibits173: Sanofi SA - Business segments
Exhibits174: Sanofi SA - Key news
Exhibits175: Sanofi SA - Key offerings
Exhibits176: Sanofi SA - Segment focus
Exhibits177: Viatris Inc. - Overview
Exhibits178: Viatris Inc. - Business segments
Exhibits179: Viatris Inc. - Key news
Exhibits180: Viatris Inc. - Key offerings
Exhibits181: Viatris Inc. - Segment focus
Exhibits182: Inclusions checklist
Exhibits183: Exclusions checklist
Exhibits184: Currency conversion rates for US$
Exhibits185: Research methodology
Exhibits186: Information sources
Exhibits187: Data validation
Exhibits188: Validation techniques employed for market sizing
Exhibits189: Data synthesis
Exhibits190: 360 degree market analysis
Exhibits191: List of abbreviations